Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease

Author： Ferdinand Keith C.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.7, 2005-07, pp. : 1091-1098

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictors of Residual Cardiovascular Risk in Patients on Statin Therapy for Primary Prevention

By  

Cardiology, Vol. 119, Iss. 4, 2011-09 ,pp. : 187-190

Karger

Access to resources Recommend Favorite

Evaluation of the Potential Role of Alirocumab in the Management of Hypercholesterolemia in Patients with High‐Risk Cardiovascular Disease

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 8, 2015-08 ,pp. : 771-779

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary prevention of cardiovascular disease with HRT

By Maclaran Kate   Stevenson John C  

Women's Health, Vol. 8, Iss. 1, 2012-01 ,pp. : 63-74

Future Medicine

Access to resources Recommend Favorite

Glycemic control and cardiovascular disease in a high-risk chronic kidney disease population

By Singh Rachandeep   Nistala Ravi   McFarlane Samy I   Whaley-Connell Adam  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 507-513

Future Medicine

Access to resources Recommend Favorite

Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials

By Allemann Sabin   Diem Peter   Egger Matthias   Christ Emanuel R.   Stettler Christoph  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 617-623

Informa Healthcare

Access to resources Recommend Favorite